As expected, NVP-BEZ235 simultaneously blocked Akt phosphorylation and mTOR activation in all three RCC cell lines, while PP242 directly inhibited mTOR activity and subsequently prevented activation of Akt. This evidence concerns the gene AKT1 and renal cell carcinoma.